Page last updated: 2024-09-05

lapatinib and olaparib

lapatinib has been researched along with olaparib in 2 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(olaparib)
Trials
(olaparib)
Recent Studies (post-2010) (olaparib)
1,9193051,4421,3131721,258

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)olaparib (IC50)
Poly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)1.538
Cytochrome P450 1A2Homo sapiens (human)0.02
CholinesteraseHomo sapiens (human)0.0035
Poly [ADP-ribose] polymerase 1Homo sapiens (human)0.1741
Cytochrome P450 2D6Homo sapiens (human)0.02
Protein mono-ADP-ribosyltransferase PARP6Homo sapiens (human)1.8
Protein mono-ADP-ribosyltransferase PARP15Homo sapiens (human)7.6216
Protein mono-ADP-ribosyltransferase PARP10Homo sapiens (human)5.2854
Protein mono-ADP-ribosyltransferase PARP16Homo sapiens (human)5.1143
Poly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)2.3349
Histamine H3 receptorCavia porcellus (domestic guinea pig)0.001
Poly [ADP-ribose] polymerase 2Homo sapiens (human)0.1866
Protein mono-ADP-ribosyltransferase PARP4Homo sapiens (human)0.4087
Protein mono-ADP-ribosyltransferase PARP3Homo sapiens (human)0.1315

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Afratis, K; Gavras, H; Karamanos, NK; Koutsakis, C; Leonardi, S; Papaioannou, D; Piperigkou, Z; Rassias, G; Rigopoulou, D; Vachlioti, E1

Other Studies

2 other study(ies) available for lapatinib and olaparib

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?
    European journal of medicinal chemistry, 2021, Jan-15, Volume: 210

    Topics: Anti-Bacterial Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Quinolines; Receptor, Bradykinin B2

2021